H. Lundbeck A/S B - stock earnings
HLUN-B.CO Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 15, 2024 BeforeMarket | - / 1.2500000000 | - | - / 5.2 billion | - |
HLUN-B.CO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | 311.0 million DKK | 4.7 billion DKK |
| 2022Q3 | 688.0 million DKK | 4.7 billion DKK |
| 2022Q2 | 505.0 million DKK | 4.5 billion DKK |
| 2022Q1 | 412.0 million DKK | 4.4 billion DKK |
HLUN-B.CO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 1.9 billion DKK | 18.2 billion DKK |
| 2021 | 1.3 billion DKK | 16.3 billion DKK |
| 2020 | 1.6 billion DKK | 17.7 billion DKK |
| 2019 | 2.7 billion DKK | 17.4 billion DKK |
HLUN-B.CO
Price: DKK35.16
52 week price:
Dividend Yield: 0.02%
5-year range yield:
Forward Dividend Yield: 2.02%
Payout Ratio: 30.30%
Payout Ratio Range:
Dividend Per Share: 0.70 DKK
Earnings Per Share: 2.31 DKK
P/E Ratio: 14.78
Exchange: CPH
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 33.0 billion
Years Paying Dividends: 2